A pilot study to evaluate the efficacy and safety of different bindarit dosages in preventing stent restenosis.
Phase of Trial: Phase II
Latest Information Update: 08 Aug 2016
At a glance
- Drugs Bindarit (Primary)
- Indications Angina pectoris; Coronary artery disease; Coronary artery restenosis; Myocardial ischaemia; Unstable angina pectoris
- Focus Therapeutic Use
- 07 Jun 2012 Actual end date (April 2011) added as reported by ClinicalTrials.gov.
- 07 Jun 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 03 Apr 2012 This trial has been completed in Italy.